Cigna to Preauthorize Genetic Tests

Clinical laboratories and pathology groups serving Cigna beneficiaries can expect to see new requirements for genetic tests used to diagnose breast cancer, colon cancer and long QT syndrome Effective this week, Cigna (NYSE: CI) in Bloomfield, Connecticut, is implementing a new program that requires genetic counseling and pre-authorization for certain genetic tests. This is an important […]
Source: Dark Daily - Category: Laboratory Medicine Authors: Tags: Coding, Billing, and Collections Laboratory Management and Operations Laboratory News Laboratory Operations Laboratory Pathology Laboratory Sales and Marketing Management & Operations News From Dark Daily Amber Trevidi breast cancer ci Source Type: news